Search plants, projects, owners, and states
1 MW Distillate Oil standby in Whitman, WA
1 MW
Nameplate Capacity
1
Generators
unit
Petroleum Liquids
Technology
2009
Operating Since
Coordinates
46.7331, -117.1583
County
Whitman, WA
Nearby Plants
Forward-looking, asset-specific exposure analytics combining climate hazards, generation variability, and counterparty risk into a single decision-grade view. Powered by InfraRisk.
See the full risk decomposition + scenarios for this asset.
| Field | EIA | GEM | Wikidata |
|---|---|---|---|
| Operator | Washington State University | — | — |
| Owner(s) | Washington State University | — | — |
| Status | Standby | — | — |
Biotech LS 0836 is a 1 MW electricity generating plant located in Whitman County, Washington. The plant began operating in 2009 and is owned and operated by Washington State University. The primary fuel source is distillate fuel oil (DFO), and the plant utilizes petroleum liquid technology. It has one generator.
The plant operates within the Avista Corporation balancing authority and the Western Electricity Coordinating Council (WECC) NERC region. Biotech LS 0836 is ranked as the 4th largest of 4 petroleum liquid plants in Washington state, and 872nd of 886 nationally.
Generated from EIA, GEM, and public data sources
Grid Region
Pacific Northwest
Market
WEIM Participant
NERC Region
WECC — Western Electricity Coordinating Council
Balancing Authority
Avista Corporation (AVA)
Grid Voltage
13.2 kV
Regulatory Status
NR — Non-Regulated
Entity Type
State
Sector
Commercial Non-CHP
Monthly net generation as reported to EIA-923 — useful for historical context. Confidence varies sharply by fuel type; the band above and the “About this data” button explain the caveats specific to this plant and how InfraSure’s in-house model handles them.
0 MWh
Latest Month
0 MWh
Annual Generation
0.0%
Capacity Factor
Forward-looking generation outlook with probabilistic ranges across weather, demand, and policy scenarios. Powered by InfraSure's generation modeling stack.
See the full forecast + scenario decomposition for this asset.
2013
$765/kW
Est. Construction Cost
Total estimated cost: $765K
Forward revenue, DSCR bands, and refinancing risk projected under price, demand, and policy scenarios. Powered by InfraSure's asset cashflow stack.
See the full revenue + DSCR projection for this asset.
This plant's balancing authority participates in CAISO's Western Energy Imbalance Market (WEIM). Direct nodal pricing data is not yet available.
No wholesale contracts disclosed in FERC EQR for this plant.
FERC EQR captures bilateral wholesale energy + capacity contracts ≥$1M/yr filed quarterly by jurisdictional sellers — covers renewable PPAs, thermal energy sales agreements, capacity contracts, and tolling agreements alike. Many plants don't appear: regulated-utility output flows to ratepayers via cost-of-service rather than bilateral contracts; small projects fall below the filing threshold; tax-equity-financed renewables route offtake to investors not utilities; merchant plants sell into ISO clearing markets without bilateral contracts. News-extracted buyer facts (below) may surface contracts disclosed only through announcements.
No insights linked yet for this plant.
Insights enrichment runs on demand — we have the pipeline, we just haven't fetched coverage for this plant yet. Request a detailed re-run and we'll add it.
No Ask reports yet for this entity.
Ask about Biotech LS 0836Forward forecasts, scenario decomposition, and risk-decision tooling for this asset.